Merck Net Margin %

: 27.03% (As of Jun. 2022)

View and export this data going back to 1949. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Merck's Net Income for the three months ended in Jun. 2022 was $3,944 Mil. Merck's Revenue for the three months ended in Jun. 2022 was $14,593 Mil. Therefore, Merck's net margin for the quarter that ended in Jun. 2022 was 27.03%.

The historical rank and industry rank for Merck's Net Margin % or its related term are showing as below:

MRK' s Net Margin % Range Over the Past 10 Years
Min: 5.97 Med: 13.88 Max: 29
Current: 29

MRK's Net Margin % is ranked better than
94.03% of 1056 companies
in the Drug Manufacturers industry
Industry Median: 3.93 vs MRK: 29.00

Merck Net Margin % Historical Data

The historical data trend for Merck's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Net Margin %

5.97

14.71

25.16

17.02

26.79

Merck Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Net Margin %																13.55	34.72	27.79	27.11	27.03

Competitive Comparison

For the Drug Manufacturers - General subindustry, Merck's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Merck Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Merck's Net Margin % distribution charts can be found below:

* The bar in red indicates where Merck's Net Margin % falls into.

Merck Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Merck's Net Margin for the fiscal year that ended in Dec. 2021 is calculated as

Net Margin	=	Net Income (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	13049	/	48704
	=	26.79 %

Merck's Net Margin for the quarter that ended in Jun. 2022 is calculated as

Net Margin	=	Net Income (Q: Jun. 2022 )	/	Revenue (Q: Jun. 2022 )
	=	3944	/	14593
	=	27.03 %

Merck (NYSE:MRK) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Merck Net Margin % Related Terms

Thank you for viewing the detailed overview of Merck's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (NYSE:MRK) » Definitions » Net Margin %

Comparable Companies

NYSE:ABBV NYSE:PFE NYSE:BMY NYSE:LLY NAS:AMGN NAS:GILD NAS:BIIB NAS:HZNP NYSE:OGN NAS:CRXT NYSE:JNJ XSWX:ROG LSE:AZN XSWX:NOVN XPAR:SAN LSE:GSK XTER:BAYN TSE:4568 TSE:4519 SHSE:600276

Traded in Other Exchanges

MRK:Peru MRK:Mexico 0QAH:UK MRK:France 6MK:Germany 6MK:Germany 6MK:Germany 6MK:Germany MRK:Chile MRK:Switzerland MRCK34:Brazil MRK:Austria MRK:Argentina

Address

2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.

Executives

Baker Douglas M Jr	director	370 WBASHA ST NORTH ST PAUL MN 55102
Oosthuizen Johannes Jacobus	officer: SVP, U.S. Market	2000 GALLOPING HILL RD KENILWORTH NJ 07033
Garay Arpa	officer: SVP Human Health Global Mktg.	2000 GALLOPING HILL RD KENILWORTH NJ 07033
Downing Cristal N	officer: Chief Comm. & Public Afrs Ofcr	2000 GALLOPING HILL RD KENILWORTH NJ 07033
Klobuchar Michael A	officer: EVP - Chief Strategy Officer	2000 GALLOPING HILL RD KENILWORTH NJ 07033
Lecointe-cephas Lisa	officer: SVP Chief Ethics & Com Officer	2000 GALLOPING HILL RD KENILWORTH NJ 07033
Litchfield Caroline	officer: EVP & CFO	2000 GALLOPING HILL RD KENILWORTH NJ 07033
Mayo Stephen	director	2000 GALLOPING HILL RD KENILWORTH NJ 07033
Li Dean Y	officer: Executive VP & President, MRL	2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Williams David Michael	officer: EVP,Chief Info&Digital Officer	MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Lavizzo-mourey Risa J	director	GENERAL ELECTRIC COMPANY 5 NECCO STREET BOSTON MA 02210
Seidman Christine E	director	MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Warden Kathy J	director	2980 FAIRVIEW PARK DRIVE FALLS CHURCH VA 22042
Craig Pamela	director	C/O ACCENTURE 161 N CLARK STREET CHICAGO IL 60601
Brun Leslie A	director	435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087